Angela Bentivegna


Affiliation: University of Milano-Bicocca
Country: Italy


  1. Bazzoni R, Bentivegna A. Role of Notch Signaling Pathway in Glioblastoma Pathogenesis. Cancers (Basel). 2019;11: pubmed publisher
    ..In this review, we try to give a comprehensive view of the contribution of Notch signaling to GBM and its possible implication as a target for new therapeutic approaches. ..
  2. Redaelli S, Maitz S, Crosti F, Sala E, Villa N, Spaccini L, et al. Refining the Phenotype of Recurrent Rearrangements of Chromosome 16. Int J Mol Sci. 2019;20: pubmed publisher
    ..We also found that in some cases a second-site CNV could explain the phenotypic heterogeneity by a simple additive effect or a pejorative synergistic effect. ..
  3. Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, et al. Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation. Genes (Basel). 2018;9: pubmed publisher
    ..VPA treatment may represent a new, interesting therapeutic approach to affect GSC proliferation and motility, but further investigations are certainly needed. ..
  4. Conconi D, Panzeri E, Redaelli S, Bovo G, Viganò P, Strada G, et al. Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cells. BMC Cancer. 2014;14:646 pubmed publisher
    ..The outcomes not only provide valuable information to deeper studying TCC carcinogenesis, but also could help in the clinic for diagnosis and prognosis of patients who will benefit from a more aggressive therapy. ..
  5. Conconi D, Sala E, Bovo G, Strada G, Dalprà L, Lavitrano M, et al. Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma. Int J Mol Sci. 2016;17:271 pubmed publisher
    ..These results provide precious advice for further study on bladder therapy; however, the clinical importance of these results should be explored. ..
  6. Bentivegna A, Milani D, Gervasini C, Castronovo P, Mottadelli F, Manzini S, et al. Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients. BMC Med Genet. 2006;7:77 pubmed
    ..3. To date mutations in CREBBP have been reported in 56.6% of RSTS patients and an average figure of 10% has ascribed to deletions...
  7. Conconi D, Bentivegna A. Analysis of Chromosomal Alterations in Urothelial Carcinoma. Methods Mol Biol. 2018;1655:3-17 pubmed publisher